scholarly journals IS LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN STILL ACCEPTABLE TO PALLIATIVE CARE PATIENTS IN THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS? A QUALITATIVE STUDY REVISITED

2014 ◽  
Vol 4 (Suppl 1) ◽  
pp. A25.2-A25
Author(s):  
Siwan Seaman ◽  
Annmarie Nelson ◽  
Simon Noble
Keyword(s):  
Molecular Weight ◽  
Palliative Care ◽  
Qualitative Study ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Cancer Associated Thrombosis

Antithrombotic Therapy for DVT/PE

1997 ◽  
Vol 17 (03) ◽  
pp. 161-162
Author(s):  
Thomas Hyers
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Oral Anticoagulants ◽  
Cost Effective ◽  
Therapeutic Agents ◽  
Great Promise ◽  
Term Therapy ◽  
Low Molecular Weight ◽  
Long Term Therapy

SummaryProblems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.

PO-97 Overall survival with warfarin versus low-molecular-weight heparin in cancer-associated thrombosis

2021 ◽  
Vol 200 ◽  
pp. S72-S73
Author(s):  
R. Patell ◽  
T. Chiasakul ◽  
R. Redd ◽  
A.M. Khan ◽  
E.P. McCarthy ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Overall Survival ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Cancer Associated Thrombosis

Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms

2007 ◽  
Vol 120 (1) ◽  
pp. 72-82.e3 ◽  
Author(s):  
Russell D. Hull ◽  
Graham F. Pineo ◽  
Rollin F. Brant ◽  
Andrew F. Mah ◽  
Natasha Burke ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Heparin Therapy ◽  
Low Molecular Weight
Sign in / Sign up

Export Citation Format

Share Document